Discover the most recent news about our Company.
Biosfer Teslab desenvolupa el Test MetBalance: una innovadora anàlisi de sang per a monitoritzar la salut metabòlica i revolucionar la
Biosfer Teslab develops MetBalance Test: an innovative blood test to monitor metabolic health and revolutionize the way you take care
Objective chronic inflammation and immune dysregulation are crucial mechanisms for atherosclerosis in rheumatoid arthritis (RA). Recent evidence suggests a link
Biosfer Teslab again in Circulation Biosfer Teslab’s R&D activity is continuous, not only in terms of optimisation and development of
Background and Aims : Patients with type 2 diabetes mellitus (T2DM) and atherogenic dyslipidaemia (AD) are at higher risk of
Background and Aims : Nuclear magnetic resonance (1H-NMR) analysis have recently used to uncover hidden quantitative lipoprotein characteristics in cardiometabolic
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows that outcomes are markedly heterogeneous between patients. This requires
Background: Atherosclerotic cardiovascular disease is the main cause of mortality worldwide and is strongly influenced by circulating low-density lipoprotein (LDL)
Treball final de grau a Biosfer Teslab Cada any a Biosfer Teslab, tenim la sort de comptar amb estudiants que
Final Thesis degree at Biosfer Teslab Every year in Biosfer Teslab, we are fortunate to have students who perform from
IX SEMINARI CIENTÍFIC IISPV “Medicina Personalitzada de Precisió” La comissió de formació de l’Institut de Recerca Sanitària Pere Virgili (IISPV)
IX IISPV SCIENTIFIC SEMINAR “Personalised Precision Medicine”. The training commission of the Pere Virgili Health Research Institute (IISPV) organised the
